elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37680981-D6CC8A19-7452-46DD-8599-11838895C4A9
Q37680981-D6CC8A19-7452-46DD-8599-11838895C4A9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37680981-D6CC8A19-7452-46DD-8599-11838895C4A9
Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.
P2860
Q37680981-D6CC8A19-7452-46DD-8599-11838895C4A9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37680981-D6CC8A19-7452-46DD-8599-11838895C4A9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b59cef730fefbabafbe9ac20de8c0facb1f8d95a
P2860
Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.